Anti-Fibrotic Therapy

NANTONG, China, July 31, 2026 Ractigen Therapeutics has received U.S. Food and Drug Administration (FDA) clearance of its Investigational...

BOSTON, Mass. | June 23, 2026 Mediar Therapeutics has announced that the first cohorts have been dosed in its...

SHANGHAI, Feb. 12, 2026 — AGCO Biomedical Technology Co., Ltd. announced that the U.S. Food and Drug Administration (FDA)...